BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 6305493)

  • 21. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial protection by chlorpromazine in mercuric chloride-induced acute renal failure in rats.
    Dobyan DC; Bulger RE
    Lab Invest; 1984 May; 50(5):578-86. PubMed ID: 6232424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats.
    Gill A; Wortham K; Costa D; Davis W; Ticho B; Whalley E
    Am J Nephrol; 2009; 30(6):521-6. PubMed ID: 19828940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
    Malis CD; Racusen LC; Solez K; Whelton A
    J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
    Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
    Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of 1,4-Dichlorobenzene (CAS No. 106-46-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1987 Jan; 319():1-198. PubMed ID: 12748734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
    Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
    Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of aminoglycoside nephrotoxicity by vitamin-D-induced hypercalcemia.
    Cohen R; Johnson K; Humes HD
    Miner Electrolyte Metab; 1988; 14(2-3):121-8. PubMed ID: 3380067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Lee KW; Jeong JY; Lim BJ; Chang YK; Lee SJ; Na KR; Shin YT; Choi DE
    Toxicology; 2009 Mar; 257(3):137-43. PubMed ID: 19152827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
    Hacke M; Schmoll HJ; Alt JM; Baumann K; Stolte H
    Clin Physiol Biochem; 1983; 1(1):17-26. PubMed ID: 6383688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin nephrotoxicity and protection by silibinin.
    Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
    Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of gentamicin on isolated glomeruli and proximal tubules of the rabbit.
    Savin V; Karniski L; Cuppage F; Hodges G; Chonko A
    Lab Invest; 1985 Jan; 52(1):93-102. PubMed ID: 3965802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
    Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
    Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats.
    Camargo SM; Francescato HD; Lavrador MA; Bianchi ML
    Biol Trace Elem Res; 2001 Dec; 83(3):251-62. PubMed ID: 11794517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
    Saad SY; Najjar TA; Alashari M
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.